Serous carcinoma. The patient performed other staging exams (breast ultrasound and mammography) which have been suspicious for carcinomatous other staging exams (breast ultrasound and mammography) which had been suspicious for carcinomatous lymphangitis. Biopsy of breast skin lesion revealed the presence of carcinomatous lymphangitis lymphangitis. Biopsy from the the breast skin lesion revealed the presence of carcinomatous lymphangitis (D), whereas immunohistochemistrynegativitynegativity for CK20, GATA3 (E) andfor CK7 (D), whereas immunohistochemistry showed showed for CK20, GATA3 (E) and positivity positivity for CK7 (F), PAX8 and WT1. The immunochemistry pattern demonstrated the ovarian origin (F), PAX8 and WT1. The immunochemistry pattern demonstrated the ovarian origin of breast lesions. Following the diagnosis of metastatic illness, the patient underwent chemotherapy with carboplatin andwww.mdpi/journal/diagnosticsmdpi/journal/diagnosticsDiagnostics 2021, 11, 2106. 10.3390/diagnosticsDiagnostics 2021, 11, 2106. 10.3390/diagnosticsDiagnostics 2021, 11,2 ofpaclitaxel with partial radiological response following three cycles. Due to inoperable disease, the patient continued chemotherapy together with the addition of bevacizumab, acquiring partial treatment response at final follow-up (about one particular year after the diagnosis of carcinomatous lymphangitis). Carcinomatous lymphangitis may well be a metastatic manifestation of different tumors; by far the most popular main sites are breast, lung and stomach, whereas in rare situations it could be because of ovarian cancer [1]. Inside the described case, an integrated diagnostic approach was quite beneficial to detect breast carcinomatous lymphangitis as an uncommon presentation of metastatic ovarian cancer. Author Contributions: Conceptualization, B.M. and M.D.G.; investigation, B.M., P.M. and M.D.G.; information curation, B.M., P.M. and M.D.G.; writing–original draft preparation, B.M. and G.T.; writing– critique and editing, M.D.G. and G.T. All authors have study and agreed to the published version on the manuscript. Funding: This analysis received no external funding. Institutional Critique Board Statement: Not applicable. Ceftazidime (pentahydrate) In Vitro Informed Consent Statement: Written informed consent was obtained from the patient to publish this paper. Information Availability Statement: Original information supporting the reported benefits are available contacting the authors. Conflicts of Interest: The authors declare no conflict of interest.ArticleThe Behavioural Outcomes of Youngsters with Autism Spectrum Disorder and also other Developmental Disabilities as Perceived by Parents through the COVID-19 LockdownKathleen Franz 1 and Michelle E. Kelly two, 1School of Psychology, Trinity College Dublin, Dublin 2, Ireland; [email protected] Department of Psychology, National College of Ireland, Mayor Street Reduce, IFSC, Dublin 1, Ireland Correspondence: [email protected]: Franz, K.; Kelly, M.E. The Behavioural Outcomes of Kids with Autism Spectrum Disorder as well as other Developmental Disabilities as Perceived by Parents during the COVID-19 Lockdown. Disabilities 2021, 1, 34760. 10.3390/disabilities1040024 Academic Editors: Janet Finlayson and Stuart Todd Received: 31 August 2021 Accepted: 6 October 2021 Published: 12 OctoberAbstract: The COVID-19 lockdown and closure of schools, clinics, and community-based solutions put children with autism spectrum disorders (ASDs) as well as other developmental disabilities (DDs) at elevated risk of adverse outcomes. This study aimed to investigate parents’ perceptions.